Stryker
Trade Stryker 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SYK
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments.
SYK Key Statistics
Stock Snapshot
As of today, Stryker(SYK) shares are valued at $360.13. The company's market cap stands at 137.72B, with a P/E ratio of 47.56 and a dividend yield of 92.8%.
On 2025-11-17, Stryker(SYK) stock moved within a range of $357.50 to $363.66. With shares now at $360.13, the stock is trading +0.7% above its intraday low and -1.0% below the session's peak.
Trading volume for Stryker(SYK) stock has reached 1.92M, versus its average volume of 2.03M.
The stock's 52-week range extends from a low of $329.16 to a high of $406.19.
The stock's 52-week range extends from a low of $329.16 to a high of $406.19.
SYK News
Truist analyst Richard Newitter raised the firm’s price target on Stryker (SYK) to $400 from $392 and keeps a Hold rating on the shares. The company’s Investor...
Wells Fargo raised the firm’s price target on Stryker (SYK) to $456 from $452 and keeps an Overweight rating on the shares. The firm notes the company’s 2025 in...
Michael Matson, an analyst from Needham, reiterated the Buy rating on Stryker. The associated price target remains the same with $448.00. Meet Your ETF AI Analy...
Analyst ratings
71%
of 31 ratingsMore SYK News
Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Stryker, retaining the price target of $450.00. Meet Your ETF AI Analyst Discover...
Stryker Corporation reported third quarter 2025 earnings of US$859 million and sales of US$6,057 million, while also raising its full-year 2025 guidance, citing...
